Skip to main content
Terug
Watch Compare

Surrozen, Inc./DE

Datakwaliteit: 100%
Ook genoteerd als SRZNW NASDAQ
SRZN
NASDAQ Manufacturing Chemicals
€ 28,58
▲ € 0,38 (1,33%)
Marktkapitalisatie: 307,27 M
Prijs
€ 26,75
Marktkapitalisatie
307,27 M
Dagbereik
52-Weeksbereik
Volume
Openen —
50D / 200D Gem.
50D / 200D Gem.

Quick Summary

Belangrijkste Punten

Negative free cash flow of -30,37 M
Capital efficient — spends only 3,68% of revenue on capex

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)-67,37%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
-2051,15%
Onder sectorgemiddelde (-54,01%)
ROIC-36,05%
Net Margin-6960,77%
Op. Margin-1210,58%

Veiligheid

Debt / Equity
N/A
Current Ratio13,15
Interest CoverageN/A

Waardering

PE (TTM|NTM)
-1,27 | -7,91
Boven sectorgemiddelde (-1,49)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1385 peers)
Metriek Aandeel Sector Mediaan
P/E -1,3 -1,5
P/B 1,6
ROE % -2051,2 -54,0
Net Margin % -6960,8 -41,5
Rev Growth 5Y % 1,8
D/E 0,3

Koersdoel Analisten

4 analisten
Buy
Huidig
€ 28,58
+35.6%
Koersdoel
€ 38,75
€ 36,00
€ 38,50
€ 42,00
Vooruitzicht
Forward K/W -7,91
Forward WPA -€ 3,57
Omzet Sch. 1,16 M

Winstschattingen

Periode WPA Sch. Omzet Sch. Analisten
FY2027 -€ 3,57
-€ 3,70 – -€ 3,43
1,16 M 2
FY2026 -€ 3,70
-€ 3,70 – -€ 3,70
7,20 M 2

Winstverassingen

Laatste 4 kwartalen
Kwartaal Geschat WPA Werkelijk WPA Verrassing
Q42025 -€ 1,24 -€ 9,62 -678,8%
Q32025 -€ 1,17 -€ 3,60 -208,1%
Q22025 -€ 1,23 -€ 1,14 +7,6%
Q12025 -€ 1,09 € 7,92 +826,5%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -67,37% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 3,48 M Net Income (TTM) -242,03 M
ROE -2051,15% ROA -246,03%
Gross Margin N/A Operating Margin -1210,58%
Net Margin -6960,77% Free Cash Flow (TTM) -30,37 M
ROIC -36,05% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 13,15
Interest Coverage N/A Asset Turnover 0,04
Working Capital 79,33 M Tangible Book Value -23,52 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,27 Forward P/E -7,91
P/B Ratio N/A P/S Ratio 88,37
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 265,12 Fwd Earnings Yield N/A
FCF Yield -9,88%
Market Cap 307,27 M Enterprise Value 225,93 M
Per Share
EPS (Diluted TTM) -32,37 Revenue / Share 0,30
FCF / Share -2,64 OCF / Share -2,63
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 3,68% FCF Conversion 12,55%
SBC-Adj. FCF -34,24 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Revenue 3,48 M 10,66 M
Net Income -242,03 M -63,56 M -43,04 M -36,00 M -441.255,0
EPS (Diluted) -32,37 -21,67 -21,33 -1,04
Gross Profit
Operating Income -42,09 M -25,54 M -45,78 M -44,34 M -438.756,0
EBITDA
R&D Expenses 29,37 M 21,13 M 27,23 M 37,01 M
SG&A Expenses
D&A 537.000,0 1,44 M 1,91 M 1,96 M
Interest Expense
Income Tax 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2020
Total Assets 98,73 M 48,47 M 46,08 M 89,44 M 93,78 M
Total Liabilities 286,49 M 69,85 M 8,15 M 13,43 M 3,51 M
Shareholders' Equity -187,76 M -21,38 M 37,94 M 76,00 M 5,00 M
Total Debt
Cash & Equivalents 89,25 M 34,57 M 36,04 M 24,69 M 987.187,0
Current Assets 91,56 M 38,93 M 41,13 M 81,31 M 1,78 M
Current Liabilities 9,93 M 7,32 M 7,15 M 9,73 M